Nucleic acid testing (NAT) in high prevalence-low resource settings.
about
Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, SudanMinipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors.Prevalence and trend of HIV infection among voluntary blood donors in China since implementation of the Blood Donation Law: a systematic review and meta-analysis.Assessment of semi-automated nucleic acid testing programme in a Regional Blood Transfusion Centre.Simultaneous detection of multiple viruses based on chemiluminescence and magnetic separation.Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India.Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy.Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia.
P2860
Q33909168-9060D35B-BA41-473C-8482-551EBAE90362Q34487699-A6A0E3DC-3C8B-4D57-91FA-2915985D51AAQ35125865-F24FCF68-DB49-46C0-B50A-55D0AA388BD9Q36248372-87E85B9E-611C-43F3-AD01-9E39465637ACQ37423887-FAFD0C85-6EF5-4C21-B5B4-99951FB3C24EQ38017710-1EAE11C0-2562-4256-A76F-76174A90853FQ40402813-EF94870D-D2BC-4ACC-B0BC-93D67155D5BCQ40475232-FBD0ACAE-7321-437C-8133-C2408C708B17Q42000353-C074CFED-5DD4-4150-A8E8-C97C3A2B24C3Q42240158-B9661D5B-E6C9-4A19-8D2C-271CF789410DQ42245717-12F2F958-6E0D-4957-958A-CA73EECD5729Q42981169-BCE78C0B-0BA6-4BE7-8E2B-3FAC5658D699Q47552167-F0B0775E-F815-4361-B5C9-5F6169A0AA64
P2860
Nucleic acid testing (NAT) in high prevalence-low resource settings.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nucleic acid testing (NAT) in high prevalence-low resource settings.
@en
type
label
Nucleic acid testing (NAT) in high prevalence-low resource settings.
@en
prefLabel
Nucleic acid testing (NAT) in high prevalence-low resource settings.
@en
P2093
P1433
P1476
Nucleic acid testing (NAT) in high prevalence-low resource settings.
@en
P2093
Jean-Pierre Allain
Magdy El Ekiaby
Nico Lelie
P356
10.1016/J.BIOLOGICALS.2009.10.015
P577
2010-01-15T00:00:00Z